Cerium Pharmaceuticals is dedicated to creating efficacious therapies for patients with kidney diseases. Cerium is currently focused on developing the first drug approved for a very rare kidney disease called Primary Membranous Nephropathy (PMN). There are approximately 75,000 PMN patients in the US and approximately 3,000 newly diagnosed PMN patients per year.
Looking for a particular Cerium Pharmaceuticals employee's phone or email?
The Cerium Pharmaceuticals annual revenue was $6 million in 2026.
Nancy Klett is the COO of Cerium Pharmaceuticals.
5 people are employed at Cerium Pharmaceuticals.
Cerium Pharmaceuticals is based in Gaithersburg, Maryland.
The NAICS codes for Cerium Pharmaceuticals are [32541, 32, 325, 3254].
The SIC codes for Cerium Pharmaceuticals are [28, 283].